🚀 Hold onto your hats, folks! Avalon GloboCare Corp (NASDAQ:ALBT) is making waves and stocks are surfing high, rocketing up 29% to $1.24 this Tuesday! Why the big splash? They just snagged a shiny new US patent, the result of a tag-team effort with MIT's Dr. Shuguang Zhang. It's all about their revolutionary 'QTY Code', a game-changer that might just turn the tide in treatments for baddies like cancer. 🌊

Remember August 30, 2023? Oh, what a day! Shares hopped up 10% when they unveiled their latest magic trick: a test from their 40%-owned lab, LSM, that sniffs out tuberculosis from just a smidge of patient's sputum. 🧪

Speaking of LSM, they're on a shopping spree! They've recently welcomed Houston's DE Laboratory LLC into their family and set up a sparkling lab in sunny Scottsdale, Arizona. 🌵

And here's the cherry on top: In 2022, LSM raked in a cool $6.3 million profit from a whopping $14.7 million revenue. Avalon's ringing the cash register, expecting their partnership with LSM to bring in a sweet symphony of ka-chings in the future. 💰🎶

‍

Disclaimer: this content is made for entertainment purposes only. This is NO INVESTMENT ADVICE